Oncological Pathology at Home: One Year of Experience
DOI:
https://doi.org/10.24950/O/142/20/4/2020Keywords:
Fever, Home Care Services, Hospital-Based, Neoplasms, NeutropeniaAbstract
Introduction: Neoplasia is considered the second disease with the highest morbidity and mortality. Hospital-level care is often unavoidable. The objective of Home Hospitalization (HH) is to minimize hospital complications and provide greater satisfaction to the patient and family/caregiver.
Material and Methods: This article reports one year of HH experience at the Unidade Local de Saúde of Castelo Branco with regard to patients with oncological pathology.
Results/Discussion: In the first year of HH, 99 patients were admitted, 22.2% (n = 22) of whom had oncological pathology. Sixty four percent were male and the average age was 65.9 years old (±12.8). The average hospital stay was 6.8 days (±3.4). Seventy seven percent had active cancer disease. The main existing neoplasias were: 31.8% lung, 22.7% hematological, 18.1% prostate and 13.6% breast. Of these, 58.8% were under chemotherapy and 17.6% had undergone recent surgery or radiation therapy. The main comorbidities found in these patients were: hypertension, type 2 diabetes mellitus, obstructive sleep apnea syndrome and chronic pain. The main reasons for hospitalization were: febrile neutropenia (36.3%), respiratory infection (27.2%) and pain control (13.6%). One patient died, one was transferred to hospital and three readmissions. Ninety days after discharge, 63.6% did not return to the hospital.
Conclusion: Hospitalization in patients with neoplasia is very common. These are at increased risk of suffering from in-hospital infections, which increases mortality. The HH is advantageous because it reduces complications and provides a better quality of life for patients, given that they are undergoing qualified treatment in their own home.
Downloads
References
Handley NR, Bekelman JE. The Oncology Hospital at Home. J Clin Oncol. 2019;37:448-52. doi: 10.1200/JCO.18.01167.
Direção Geral da Saúde. Hospitalização Domiciliária em idade adulta: Norma nº 020/2018 de 20/12/2018. Lisboa: DGS; 2018.
Cunha V, Escarigo MC, Correia J, Nortadas R, Azevedo PC, Beirão P, et al; Hospitalização Domiciliária: Balanço de um Ano da Primeira Unidade Portuguesa; Rev Soc Port Med Intern. VOL.24 | N.º 4 | OUT/DEZ 2017
Guimaraes MD, Bitencourt AG, Marchiori E, Chojniak R, Gross JL, Kundra V. Imaging acute complications in cancer patients: what should be evaluated in the emergency setting? Cancer Imaging. 2014;14:18. doi: 10.1186/1470-7330-14-18.
Cotta RM, Morales Suárez-Varela M, Cotta Filho JS, Llopis González A, Días Ricós JA, Real ER. La hospitalización domiciliaria ante los cambios demográficos y nuevos retos de salud. Rev Panam Salud Publica. 2002;11:253-61. 6.
Atalaia G, Vasconcelos P, Bragança N. Neutropenia febril. Rev Clin Hosp Prof Dr Fernando Fonseca. 2015; 3: 13-9.
Talcott JA, Finberg R, Mayer RJ, Goldman L. The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation. Arch Intern Med. 1988148:2561-8.
Klastersky J, Paesmans M, Rubenstein EB, Boyer M, Elting L, Feld R. The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol. 2000;18:3038-51.
Taplitz RA, Kennedy EB, Bow EJ, Crews J, Gleason C, Hawley DK, et al. Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update. J Clin Oncol. 2018;36:1443-53. doi: 10.1200/JCO.2017.77.6211.
Hendricks AM, Loggers ET, Talcott JA. Costs of home versus inpatient treatment for fever and neutropenia: analysis of a multicenter randomized trial. J Clin Oncol. 20110;29:3984-9. doi: 10.1200/JCO.2011.35.1247. Erratum in: J Clin Oncol. 2011;29:4847.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Medicina Interna